Skip to main content

The Wistar Institute

|

The Wistar Institute’s Dr. Kazuko Nishikura Launches Preclinical Testing of New Melanoma Immunotherapy

Wistar professor Kazuko Nishikura, Ph.D., has led the way in foundational biomedical research on RNA for decades. Her laboratory discovered the role genes in the ADAR family play in editing RNA. A new grant from the Melanoma Research Foundation supp…
Read more
|

The Wistar Institute Receives $600,000 Grant to Expand Apprenticeship Programs in its Hubert J.P. Schoemaker Education and Training Center

PHILADELPHIA — (January 30, 2025) — The Wistar Institute’s Hubert J.P. Schoemaker Education and Training Center is expanding its signature apprenticeship programs and bolstering job opportunities in the life science sector thanks to a recent $600,00…
Read more
|

Michela Perego on Life Inside & Outside of the Lab

Cellular biologist Michela Perego, Ph.D., was born in Monza, the capital city of Brianza, a northern Italian province well known for Formula One race car driving. She grew up in a family of non-scientists yet found her passion for science in high sc…
Read more
|

Wistar Scientists Recognized at International Society for Vaccines Conference

Wistar researchers were recognized for their leadership and contributions to vaccinology recently at the International Society for Vaccines (ISV) annual Congress. The conference, held in October in Seoul, also featured presentations by scientists in…
Read more
|

The Wistar Institute’s Head of HIV Cure and Viral Diseases Center Luis Montaner Shares Why He Thinks We Can Attain an HIV Cure

Finding a cure has long been the holy grail of HIV research. Now new discoveries are putting that goal within reach, according to Wistar’s Luis Montaner, D.V.M., D.Phil. As director of the institute’s new HIV Cure and Viral Diseases Center, Montane…
Read more
|

Newsweek Magazine in Collaboration with Best Practice Institute Recognizes The Wistar Institute in 2025 ‘Excellence Index’

PHILADELPHIA — (December 20th, 2024) — In its annual Excellence Index, Newsweek and the Best Practice Institute has recognized The Wistar Institute as one of the world’s top 1000 companies. Wistar led the way as the top-ranked company in the Healthc…
Read more
|

How The Wistar Institute’s Dr. Dan Claiborne Engineers CAR T Cells to Fight HIV

Assistant professor Daniel Claiborne, Ph.D., pursues one of the hottest up-and-coming areas of research: CAR T cells, which are engineered immune cells designed to attack specific target Dr. Claiborne’s work focuses on HIV. As Dr. Claiborne prepares…
Read more
|

The Wistar Institute Receives Two Biomedical Research Grants from the V Foundation for Cancer Research

PHILADELPHIA — (December 10, 2024) — The Wistar Institute assistant professors Nan Zhang, Ph.D., and Noam Auslander Ph.D., have both received independent funding totaling $1.2 million over the next three years for cancer research projects from the V…
Read more
|

Wistar Institute Researchers Design Novel Immunotherapy for Brain Cancer

PHILADELPHIA — (December 3rd, 2024) — The Wistar Institute’s David B. Weiner, Ph.D. — Executive Vice President, director of the Vaccine & Immunotherapy Center and W.W. Smith Charitable Trust Distinguished Professor in Cancer Research — and his lab h…
Read more
|

The Wistar Institute Awarded $2 Million RACP Grant from Shapiro Administration for New Center for Advanced Therapeutics

PHILADELPHIA — (Nov. 27, 2024) — Governor Josh Shapiro’s Administration, through the Commonwealth of Pennsylvania Redevelopment Assistance Capital Program (RACP), has granted The Wistar Institute $2 million to fund its new Center for Advanced Therap…
Read more